Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00216320 · ClinicalTrials.gov registry record · NA

Efficacy of the WalkAide and AFOs for CVA

A NA study of Stroke, sponsored by Innovative Neurotronics.

Completed
Registry status
NA
Development phase
121
Enrollment target
5
Study locations

NCT00216320: Completed NA study of Stroke, sponsored by Innovative Neurotronics.

NCT00216320 is a NA study of Stroke that has completed, run by Innovative Neurotronics. The registered enrollment target is 121 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00216320, a NA study of Stroke, has completed, sponsored by Innovative Neurotronics.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target
5
Study locations

Study Summary

To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop. The comparison will involve physical measurements (e.g. walking speed, physiological cost index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and acceptance of the technology by stroke survivors.

Conditions Studied

Interventions

  • DEVICE WalkAide
  • DEVICE AFO

Study Locations (5)

Arizona

  • Banner Good Samaritan Medical Center - Phoenix

California

  • San Francisco VA Medical Center - San Francisco

Missouri

  • Washington University - St Louis

Pennsylvania

  • University of Pittsburgh, Department of PM&R - Pittsburgh

Texas

  • Texas Institute of Rehabilitation Research - Houston

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2005-09
Est. Completion 2008-11
Phase NA

Sponsor

Innovative Neurotronics

2 total trials

What the Registry Record Tells You About NCT00216320

The ClinicalTrials.gov registry entry for NCT00216320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Innovative Neurotronics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which WalkAide is the first listed.

NCT00216320 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Missouri.

Frequently Asked Questions

What is clinical trial NCT00216320 about?

NCT00216320 is a clinical study titled "Efficacy of the WalkAide and AFOs for CVA". To assess the effectiveness of a new stimulator (WalkAide) for the treatment of foot drop. The comparison will involve physical measurements (e.g. walking speed, physiological cost index, Modified Rivermead Mobility Index, etc.) and questionnaires on the quality of life and acceptance of the technol...

What is the current status of trial NCT00216320?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2005-09. Estimated completion is 2008-11.

What conditions does trial NCT00216320 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT00216320?

The interventions under investigation include: WalkAide (DEVICE), AFO (DEVICE).

Who is sponsoring clinical trial NCT00216320?

This trial is sponsored by Innovative Neurotronics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00216320 being conducted?

This trial has 5 study locations across Arizona, California, Missouri, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.